安慰剂效应与抑郁症神经调控:一项Meta分析及共享机制评估
本系统综述与Meta分析检索PubMed/Medline和Google Scholar,纳入34项安慰剂效应功能MRI和PET神经影像研究,发现左侧背外侧前额叶皮层、左侧膝下前扣带皮层/腹侧纹状体等激活簇,以及右侧基底节和右侧背侧前扣带皮层失活簇;经颅磁刺激和脑深部电刺激的抑郁症治疗靶点分别与左侧背外侧前额叶皮层簇和膝下前扣带皮层簇重叠,作者建模展示了该重叠对临床试验疗效测量的重要影响。
要点
- 34项神经影像研究显示安慰剂效应存在左侧背外侧前额叶皮层等三个激活簇和右侧基底节等两个失活簇。
- 经颅磁刺激和脑深部电刺激的抑郁症治疗靶点分别与左侧背外侧前额叶皮层簇和膝下前扣带皮层簇重叠。
- 作者建模展示了该重叠对安慰剂对照临床试验疗效测量的重要影响。
核心结论
- 研究识别出健康个体和患者群体中安慰剂效应涉及的一组共同脑区,并提供这些脑区与抑郁症治疗靶点重叠的证据。
- 作者建模展示了该重叠对临床试验疗效测量的重要影响。
研究设计与样本
- 系统综述与Meta分析,检索PubMed/Medline和Google Scholar,纳入健康受试者和患者群体的安慰剂效应功能MRI和PET神经影像研究,提取坐标进行激活似然估计(ALE)Meta分析。
- 另检索经颅磁刺激(TMS)和脑深部电刺激(DBS)治疗抑郁症的干预研究,提取靶点坐标与安慰剂效应图进行空间比较分析。
- 共识别1169篇文章,最终纳入34项安慰剂效应神经影像研究。
主要发现
- 三个显著激活簇:左侧背外侧前额叶皮层(DLPFC)(x = -41, y = 16, z = 34)、左侧膝下前扣带皮层(sgACC)/腹侧纹状体(x = -8, y = 18, z = -15)和右侧吻侧前扣带皮层(rACC)(x = 4, y = 42, z = 10)。
- 两个显著失活簇:右侧基底节(x = 20, y = 2, z = 7)和右侧背侧前扣带皮层(dACC)(x = 1, y = -5, z = 45)。
- TMS和DBS的抑郁症治疗靶点分别与左侧DLPFC簇和sgACC簇重叠。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
There is growing evidence that placebo effects can meaningfully modulate the brain. However, there has been little consideration of whether these changes may overlap with regions/circuits targeted by depression treatments and what the implications of this overlap would be on measuring efficacy in placebo-controlled clinical trials. In this systematic review and meta-analysis, we searched PubMed/Medline and Google Scholar for functional MRI and PET neuroimaging studies of placebo effects. Studies recruiting both healthy subjects and patient populations were included. Neuroimaging coordinates were extracted and included for Activation Likelihood Estimation (ALE) meta-analysis. We then searched for interventional studies of transcranial magnetic stimulation (TMS) and deep brain stimulation (DBS) for depression and extracted target coordinates for comparative spatial analysis with the placebo effects maps. Of 1169 articles identified, 34 neuroimaging studies of placebo effects were included. There were three significant clusters of activation: left dorsolateral prefrontal cortex (DLPFC) (x = -41, y = 16, z = 34), left sub-genual anterior cingulate cortex (sgACC)/ventral striatum (x = -8, y = 18, z = -15) and the right rostral anterior cingulate cortex (rACC) (x = 4, y = 42, z = 10). There were two significant deactivation clusters: right basal ganglia (x = 20, y = 2, z = 7) and right dorsal anterior cingulate cortex (dACC) (x = 1, y = -5, z = 45). TMS and DBS targets for depression treatment overlapped with the left DLPFC cluster and sgACC cluster, respectively. Our findings identify a common set of brain regions implicated in placebo effects across healthy individuals and patient populations, and provide evidence that these regions overlap with depression treatment targets. We model the statistical impacts of this overlap and demonstrate critical implications on measurements of clinical trial efficacy for this field.
引用
- Burke MJ, Romanella SM, Mencarelli L, et al. Placebo effects and neuromodulation for depression: a meta-analysis and evaluation of shared mechanisms. Mol Psychiatry. 2021. PMID: 34903861. doi:10.1038/s41380-021-01397-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。